By combining LED technology and nanomaterials, researchers have created a therapy that eliminates cancer cells using ...

Genomic profiling revealed druggable targets in 39% of advanced prostate cancer cases, guiding personalised treatments.

A new review was published in Volume 12 of Oncoscience on October 13, 2025, titled "Targeted therapies and resistance ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

Delcath Systems Inc. (NASDAQ:DCTH) saw its shares rise 2.2% in premarket trading Thursday after new research underscored the potential survival benefits of its liver-targeted treatment for metastatic ...

Researchers at the University of Southampton have identified a new subtype of lymphoma which could pave the way to improved ...

Texas A&M scientists have unlocked new potential for astatine-211, a rare and short-lived element, as a highly precise cancer-fighting isotope. Its alpha emissions destroy tumor cells while sparing ...

Dr LK Medina-Kauwe developed a bioengineered delivery system to treat resistant and metastatic tumors, highlighting nano-bioparticles ...

Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its proprietary PALM nanotechnology, is partnering with Alcami Corp. in North Carolina to ...

Pancreatic cancer, also known as pancreatic ductal adenocarcinoma, is one of the most aggressive types of cancer. Despite ...

Researchers have evidence that inside shark DNA are single chain antibodies that just might help cure cancer. These flexible, ...

HR-positive/HER2-negative breast cancer grows with estrogen or progesterone, lacking high HER2 protein levels, making hormone ...